30.76USD+4.48%Mkt Cap: 524.39M $P/E: —1d ago
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. T…
Industry Peers
Health Information Services$32.06BUSDP/E 35.0
$13.38BUSDP/E 88.5
$9.62BUSD
$8.27BUSDP/E 37.0
$6.65BUSD
$5.65BUSD
$4.44BUSDP/E 34.6
$3.43BUSDP/E 160.1
$2.24BUSD
$2.14BUSDP/E 106.8
$1.71BUSD
$1.41BUSD
$1.17BUSD
$1.13BUSD
$1.06BUSDP/E 52.0
$874.42MUSDP/E Infinity
$845.49MUSDP/E 43.2
$672.72MUSDP/E 68.1
$637.77MUSD
$581.77MUSDP/E 27.4
$584.81MUSD
$552.27MUSDP/E 13.1
$516.62MUSD
$494.46MUSDP/E 56.3
$460.71MUSDP/E 25.8
$446.52MUSDP/E 25.4
$393.58MUSDP/E 90.5
$368.70MUSDP/E 45.6
$321.33MUSD
$230.81MUSDP/E 14.1
$224.12MUSDP/E 18.2
$217.63MUSD
$182.96MUSD
$156.35MUSDP/E 39.4
$168.48MUSD
$148.67MUSDP/E 29.6
$123.72MUSDP/E Infinity
$124.79MUSDP/E 18.5
$113.48MUSDP/E 25.4
$99.01MUSDP/E 17.9
$86.66MUSD
$65.63MUSDP/E 11.3
$62.29MUSDP/E 22.6
$57.34MUSD
$47.87MUSDP/E 57.6
$49.50MUSD
$40.55MUSDP/E 38.7
$39.14MUSD
$31.93MUSD
$26.93MUSDP/E 26.0
$22.91MUSDP/E 54.8
$20.17MUSD
$18.43MUSD
$12.99MUSD
$13.69MUSD
$12.35MUSD
$11.72MUSD
$9.78MUSDP/E 15.1
$6.67MUSD
$6.50MUSD
$5.63MUSD
$4.88MUSD
$3.78MUSDP/E Infinity
$3.83MUSDP/E 0.0
$3.40MUSD
$2.98MUSD
$2.70MUSD
$2.16MUSDP/E Infinity
$693.4KUSD
$548.9KUSDP/E 0.0
$282.6KUSD
—
—
CRY
GraniteShares YieldBOOST CRCL ETF—
—
EYES
Corgi Data & Surveillance ETF—P/E 30.8
Indicators:|
Key Statistics
Company
Market Cap524.39M $
Enterprise Value5.25B $
Revenue (TTM)978.76M $
Gross Profit649.05M $
Net Income (TTM)-284.28M $
Revenue/Share59.18 USD
Last Price30.76 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees3.0K
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)4.50
PEG—
EV/EBITDA9.84
EV/Revenue5.36
P/S0.54
P/B-2.17
EPS (TTM)-17.33
EPS (Forward)6.84
52W Range
11.5031% of range74.07
52W High74.07 USD
52W Low11.50 USD
Profitability
Gross Margin67.23%
Oper. Margin7.55%
EBITDA Margin54.49%
Profit Margin-29.45%
ROE163.47%
ROA-5.82%
Growth
Revenue Growth5.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF117.32M $
CapEx (TTM)129.60M $
FCF Margin11.13%
FCF Yield20.77%
Net Debt4.72B $
Net Debt/EBITDA8.84
Balance Sheet
Debt/Equity-26.54
Current Ratio1.28
Quick Ratio0.93
Book Value/Sh-14.1840 USD
Cash/Share1.251 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:40
Split DateSep 23, 2024
Analyst Consensus
Rating—
Target (Mean)36.83 USD
Upside (mean)+19.7%
Target Range22.00 USD – 61.00 USD
$22.00+19.7% to mean$61.00
# Analysts6
Ownership
Shares Out.17.05M
Float5.76M
Insiders7.45%
Institutions91.02%
Short Interest
Short Ratio7.3d
Short % Float9.47%
Short % Out.5.73%
Shares Short976.65K
Short (prev mo.)1.17M
Technical
SMA 5027.87 (+10.4%)
SMA 20032.96 (-6.7%)
Beta0.70
S&P 52W Chg20.25%
Avg Vol (30d)99.47K
Avg Vol (10d)97.09K
Technical Indicators
RSI (14)51.9
MACD0.6222
MACD Signal1.2377
MACD Hist.-0.6155
BB Upper35.24 USD
BB Middle31.42 USD
BB Lower27.59 USD
BB Width24.36%
ATR (14)2.781 USD
Vol Ratio (20d)1.13x